Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Affiliated Managers ( AMG) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock is already pricing in higher asset flows.

Apollo ( APOL) rated new Buy at Goldman. $54 price target. New enrollment declines should begin to stabilize by the August quarter.

Blackstone ( BX) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company was also removed from the Conviction List. Valuation call.

Carefusion ( CFN) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $30 price target.

Columbia Sportswear ( COLM) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $70 price target. Sales outlook remains strong.

Dr. Pepper Snapple ( DPS) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $37 price target. Company is facing higher commodity costs.

Education Management ( EDMC) downgraded at Goldman to Sell from Neutral, Goldman Sachs said. $18 price target. Company is most exposed to new regulations.

Energizer ( ENR) downgraded at UBS from Buy to Neutral, UBS said. $76 price target. Focus on Hydro razor could hurt other divisions.

Ensco ( ESV) upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. $75 price target. Stock is pricing in the recent ban in the Gulf of Mexico.

Hershey ( HSY) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Price increases should help drive earnings growth. $59 price target.

IBM ( IBM) downgraded at Canaccord from Buy to Hold, Canaccord Genuity said. Valuation call, based on a $180 price target.

Jack in the Box ( JACK) downgraded at Credit Suisse to Underperform from Neutral. Overpaying for a post-refranchising business, Credit Suisse said. Price target lowered by a dollar to $20.

Janus ( JNS) upgraded at Wells from Market Perform to Outperform. Net outflows should begin to decelerate.

Medtronic ( MDT) upgraded at Wells from Market Perform to Outperform. Growth is accelerating.

Magellan Health ( MGLN) rated new Underperform at BofA/Merrill. $50 price target. Organic growth will likely lag peers.

Monsanto ( MON) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Valuation call, based on a $78 price target.

Navistar ( NAV) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $89 price target. Company is seeing higher demand for its lower-emission truck engines.

Noble ( NE) upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. $60 price target. Company is leveraged to rising oil prices.

National Semiconductor ( NSM) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $25 price target. See little upside potential from the NSM bid.

Rowan ( RDC) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Valuation call, based on a $57 price target.

Transocean ( RIG) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $120 price target. Sector has lagged the broader market.

End of report.
This article was written by a staff member of TheStreet.